Loading...

FITC anti-mouse CD3 Antibody

Pricing & Availability
Clone
17A2 (See other available formats)
Regulatory Status
RUO
Other Names
T cell antigen receptor complex, T3
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
17A2
C57BL/6 splenocytes stained with 17A2 FITC and 145-2C11 PE
  • 17A2
    C57BL/6 splenocytes stained with 17A2 FITC and 145-2C11 PE
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
100203 50 µg 29€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100204 500 µg 115€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD3, also known as T3, is a member of the Ig superfamily and primarily expressed on T cells, NK-T cells, and at different levels on thymocytes during T cell differentiation. CD3 is composed of CD3ε, δ, γ and ζ chains. It forms a TCR complex by associating with TCR α/β or γ/δ chains. CD3 plays a critical role in TCR signal transduction, T cell activation, and antigen recognition by binding the peptide/MHC antigen complex

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
γδTCR-positive T-T hybridoma D1
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Additional reported application (for relevant formats) include: spatial biology (IBEX)1,2.

Application References

(PubMed link indicates BioLegend citation)
  1. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  2. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  2. Jiang W, et al. 2017. Sci Rep. 7:6501. PubMed
  3. Petrova T, et al. 2020. Sci Rep. 10:3479. PubMed
  4. Zhang H, et al. 2021. Front Immunol. 12:644520. PubMed
  5. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  6. Lee JH, et al. 2022. EBioMedicine. 77:103903. PubMed
  7. Zhu Y, et al. 2022. Nat Commun. 13:4282. PubMed
  8. Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
  9. Harsha Krovi S, et al. 2020. Nat Commun. 4.790277778. PubMed
  10. Dai L, et al. 2020. Cell. 182(3):722-733.e11. PubMed
  11. Xing J, et al. 2021. Cell Reports. 35(12):109205. PubMed
  12. Zaman R, et al. 2021. Immunity. :. PubMed
  13. Lin W, et al. 2020. Theranostics. 10:4871. PubMed
  14. Gawish R, et al. 2022. Elife. 11:. PubMed
  15. Qiao Y, et al. 2021. Oncoimmunology. 10:1947569. PubMed
  16. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  17. Manukian G, et al. 2021. Int J Radiat Oncol Biol Phys. 110:1341. PubMed
  18. Jiang Q, et al. 2022. Theranostics. 12:59. PubMed
  19. Wilhelm J, et al. 2021. J Control Release. 329:353. PubMed
  20. Ford K, et al. 2020. Cancer Res. 80:1846. PubMed
  21. Delvecchio FR, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1543. PubMed
  22. Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed
  23. Tang L, et al. 2021. Oncol Lett. 22:605. PubMed
  24. Kim D, et al. 2021. Nanomicro Lett. 13:31. PubMed
  25. Miller CM, et al. 2020. J Virol. 94:00:00. PubMed
  26. Boyd DF, et al. 2020. Nature. 587:466. PubMed
  27. Wu X, et al. 2012. Biochem Pharmacol. 84:1164. PubMed
  28. Du Q, et al. 2019. Front Microbiol. 10:2050. PubMed
  29. Song C, et al. 2019. Nat Commun. 10:3745. PubMed
  30. Liu QZ, et al. 2018. Front Immunol. 1.131944444. PubMed
  31. Chou YJ, et al. 2020. Sci Rep. 10:8422. PubMed
  32. Bromley SK, et al. 2020. Cell Reports. 32(9):108085. PubMed
  33. Turner JA, et al. 2020. Immunity. 53:1202. PubMed
  34. Jiang W, et al. 2021. Oncol Lett. 22:625. PubMed
  35. Choi YY, et al. 2021. Cell Death Dis. 12:826. PubMed
  36. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  37. Zhang S, et al. 2022. Acta Pharm Sin B. 12:3124. PubMed
  38. Steubing RD, et al. 2022. Brain Behav Immun Health. 24:100493. PubMed
  39. Mei S, et al. 2022. Front Immunol. 13:911164. PubMed
  40. Lu H, et al. 2021. Autophagy. 17:2511. PubMed
  41. Bao H, et al. 2020. Mol Med Rep. 4.675. PubMed
  42. Sun CC, et al. 2020. Genome Med. 0.553472222. PubMed
  43. Schmidleithner L et al. 2019. Immunity. 50(5):1232-1248 . PubMed
  44. Diao L, et al. 2022. iScience. 25:105511. PubMed
  45. Bangs DJ, et al. 2022. Cell Rep. 38:110266. PubMed
  46. Huang Y, et al. 2021. Radiother Oncol. 162:34. PubMed
  47. Zhao J, et al. 2022. J Nanobiotechnology. 20:62. PubMed
  48. Ren J, et al. 2021. Theranostics. 11:304. PubMed
  49. Tan X, et al. 2021. Front Oncol. 11:768222. PubMed
  50. Oliva Chávez AS, et al. 2021. Nat Commun. 12:3696. PubMed
  51. Liu Q, et al. 2021. Cell Death Dis. 12:240. PubMed
  52. Fu Y, et al. 2020. Mol Ther. 1214:28. PubMed
  53. Antonia O Cuff et al. 2017. Wellcome open research. 2:39 . PubMed
  54. Davis FM, et al. 2019. Arterioscler Thromb Vasc Biol. 39:2353. PubMed
  55. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  56. Lesmeister M, et al. 2005. Reprod Biol Endocrinol. 29:74. PubMed
  57. Dolgova EV, et al. 2022. Int J Mol Sci. 23:. PubMed
  58. Mostafavi H, et al. 2022. PLoS Pathog. 18:e1010185. PubMed
  59. Sala D, et al. 2022. Mol Ther Methods Clin Dev. 25:170. PubMed
  60. Starkl P, et al. 2020. Immunity. 53(4):793-804.e9. PubMed
  61. Ning X, et al. 2019. Mol Cell. 74:19. PubMed
  62. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  63. Deng P, et al. 2022. Cells. 11:. PubMed
  64. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  65. Zhan Y, et al. 2021. JCI Insight. 6:. PubMed
  66. Yu AI, et al. 2020. Cell Rep. 107471:31. PubMed
  67. Jiang S, et al. 2020. Scand J Immunol. e12867:91. PubMed
  68. Perner C, et al. 2020. Immunity. 53(5):1063-1077.e7. PubMed
  69. White C, et al. 2014. J Immunol. 193:5933. PubMed
  70. Chen Y, et al. 2012. PLoS One. 7:e47190. PubMed
  71. Solanki A, et al. 2018. Development. 145. PubMed
  72. Shields BD, et al. 2019. Cancer Res. 79:1113. PubMed
  73. Dang Y, et al. 2022. Cancer Cell Int. 22:88. PubMed
  74. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  75. Geng T, et al. 2022. Methods Mol Biol. 2585:71. PubMed
  76. Lee M, et al. 2014. PLoS One. 9:112666. PubMed
  77. Mingozzi F, et al. 2016. EMBO Mol Med. 8: 1039 - 1051. PubMed
  78. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  79. Kimball AS et al. 2019. Immunity. 51(2):258-271 . PubMed
  80. Naing A et al. 2019. Cell reports. 26(5):1242-1257 . PubMed
  81. Yang S, et al. 2019. Nat Commun. 10:2782. PubMed
  82. Carr RM, et al. 2021. Nat Commun. 12:2901. PubMed
  83. Pervaiz N, et al. 2021. Pigment Cell Melanoma Res. 34:918. PubMed
  84. Sun Y, et al. 2022. Nat Commun. 13:3916. PubMed
  85. Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed
  86. Wang X, et al. 2018. Mol Med Rep. 17:1660. PubMed
  87. Lee JS et al. 2018. Cell. 174(6):1559-1570 . PubMed
  88. Comazzetto S et al. 2018. Cell stem cell. 24(3):477-486 . PubMed
  89. Littwitz-Salomon E, et al. 2021. Nat Commun. 12:5376. PubMed
  90. Hanasoge Somasundara AV, et al. 2021. Cell Rep. 37:110099. PubMed
  91. Shi R, et al. 2022. Theranostics. 12:875. PubMed
  92. Jie X, et al. 2022. J Immunother Cancer. 10:. PubMed
  93. Chen Q, et al. 2016. Nat Commun. 7:13193. PubMed
  94. Bogie JF, et al. 2020. Ther Adv Chronic Dis. 11:2040622320947378. PubMed
  95. Li Y, et al. 2020. Cell Stem Cell. 27(5):732-747.e7. PubMed
  96. Omori S, et al. 2021. Cell Reports. 34(6):108734. PubMed
  97. Sreekumar PG, et al. 2018. J Control Release. 283:94. PubMed
  98. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  99. Li W, et al. 2019. Nat Commun. 10:3349. PubMed
  100. Xu X, et al. 2018. Cell. 175:1336. PubMed
  101. Reismann D, et al. 2017. Nat Commun.. 10.1038/s41467-017-01538-9. PubMed
  102. Ishidome T et al. 2017. EBioMedicine. 22:89-99 . PubMed
  103. Ding Y, et al. 2022. Cell Death Dis. 13:996. PubMed
  104. Tang X, et al. 2022. Cell Rep. 41:111673. PubMed
  105. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  106. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  107. Zhou H, et al. 2022. Oncoimmunology. 11:2057892. PubMed
  108. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  109. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  110. Koren E, et al. 2022. Nat Commun. 13:4628. PubMed
  111. Zhang C, et al. 2022. Nat Commun. 13:3468. PubMed
  112. Chen X, et al. 2021. Cell Rep. 37:109991. PubMed
  113. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  114. Zuo S, et al. 2021. J Immunother Cancer. 9:. PubMed
  115. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  116. Harb H, et al. 2021. Immunity. 54(6):1186-1199.e7. PubMed
  117. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  118. Elahi S, et al. 2020. Stem Cell Res. 43:101710. PubMed
  119. Akhter N, et al. 2016. J Biol Chem. 291: 23672 - 23680. PubMed
  120. Huang B, et al. 2015. PLoS One. 10: 0134715. PubMed
  121. Markey K, et al. 2014. J Immunol. 192:5426. PubMed
  122. Moon HG et al. 2018. Immunity. 49(2):275-287 . PubMed
  123. Ren W, et al. 2018. Mucosal Immunol. 12:531. PubMed
  124. Liu W, et al. 2021. Cell Death Discov. 7:136. PubMed
  125. França TT, et al. 2021. JCI Insight. 6:. PubMed
  126. Carbone C, et al. 2021. J Immunother Cancer. 9:. PubMed
  127. Shannon JP, et al. 2021. STAR Protoc. 2:100790. PubMed
  128. Sun C, et al. 2022. J Adv Res. 35:71. PubMed
  129. Du J, et al. 2012. Stem Cells. 30:1447. PubMed
  130. Weinheimer-Haus E, et al. 2014. PLoS One. 9:91355. PubMed
  131. Zheng L, et al. 2020. Front Oncol. 10:531131. PubMed
  132. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  133. Choi EW, et al. 2020. Sci Rep. 10:12001. PubMed
  134. Yu X, et al. 2019. Nat Commun. 10:574. PubMed
  135. Cohen M et al. 2018. Cell. 175(4):1031-1044 . PubMed
  136. Ma W, et al. 2017. Cell Death & Disease. 10.1038/cddis.2017.47. PubMed
  137. Yang Z, et al. 2021. Onco Targets Ther. 14:4239. PubMed
  138. Puigdelloses M, et al. 2021. J Immunother Cancer. 9:. PubMed
  139. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  140. Port JR, et al. 2020. J Virol. 94:. PubMed
  141. Rashid MH, et al. 2021. Oncol Rep. 45:1171. PubMed
  142. Li Y, et al. 2021. Cell Death Dis. 12:1001. PubMed
  143. Alsina-Sanchis E, et al. 2020. Mol Cancer Res. . PubMed
  144. Shannon JP, et al. 2021. Immunity. 54(2):276-290.e5. PubMed
  145. Zhang W, et al. 2019. Mar Drugs. 0.845138889. PubMed
  146. Nowlan B, et al. 2019. Haematologica. 105:71. PubMed
  147. Zhang W, et al. 2020. Nat Commun. 11:1187. PubMed
  148. Yu H, et al. 2021. Front Oncol. 11:736882. PubMed
  149. Xiao Y, et al. 2022. Nat Commun. 13:758. PubMed
  150. Zhang R, et al. 2022. Front Pharmacol. 13:870848. PubMed
  151. Ali S, et al. 2021. PLoS One. 16:e0246646. PubMed
  152. Yang Z, et al. 2021. Nat Commun. 12:4852. PubMed
  153. Pandit M, et al. 2021. Eur J Immunol. 51:1461. PubMed
  154. Lingegowda H, et al. 2022. Front Reprod Health. 3:726936. PubMed
  155. He J, et al. 2020. Evid Based Complement Alternat Med. 2020:5637507. PubMed
  156. Roy S, et al. 2019. Front Immunol. 2.404166667. PubMed
  157. Scally S, et al. 2017. Nat Commun. . 10.1038/s41467-017-01924-3. PubMed
  158. Yi H, et al. 2021. Front Immunol. 12:719189. PubMed
  159. Qi J, et al. 2021. Nat Commun. 12:4755. PubMed
  160. Bent EH, et al. 2021. Nat Commun. 12:6218. PubMed
  161. Zhang YN, et al. 2021. Sci Adv. 7:eabj3107. PubMed
  162. Murdock BJ, et al. 2021. JCI Insight. 6:. PubMed
  163. Robertson TF, et al. 2021. J Cell Biol. 220:. PubMed
  164. Mohammadi MR, et al. 2021. Commun Biol. 4:685. PubMed
  165. Li X, et al. 2021. Cell Death Dis. 12:314. PubMed
  166. Wang Z, et al. 2021. Acta Pharm Sin B. 694:11. PubMed
  167. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  168. Wu L, et al. 2020. Cell Rep. 33:108327. PubMed
  169. Zan H, et al. 2017. Nat Commun. 8:14244. PubMed
  170. Cabrera-Perez J, et al. 2016. J Immunol. 197: 1692 - 1698. PubMed
  171. Kang J, Lee J, Chang J 2016. PLoS One. 11: 0157015. PubMed
  172. Cabrera-Perez C, et al. 2015. J Immunol . 194:1609-20. PubMed
  173. Chen X, et al. 2019. Med Sci Monit. 25:5389. PubMed
  174. Zhang X, et al. 2021. Nat Commun. 12:4536. PubMed
  175. Smith-Díaz CC, et al. 2021. Front Oncol. 11:709543. PubMed
  176. Tsai HI, et al. 2021. EMBO Mol Med. 13:e12834. PubMed
  177. Wang J, et al. 2022. Clin Transl Med. 12:e718. PubMed
  178. Lai Y, et al. 2022. Clin Transl Med. 12:e999. PubMed
  179. Zhang J, et al. 2022. Biomater Res. 26:44. PubMed
  180. Li M, et al. 2021. Br J Pharmacol. 178:2617. PubMed
  181. Yang YS, et al. 2022. Nat Commun. 13:6175. PubMed
  182. Baumann D, et al. 2020. Nat Commun. 1.969444444. PubMed
  183. Chen C, et al. 2020. Front Cell Neurosci. 14:8. PubMed
  184. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  185. Chen Y, et al. 2022. Nat Commun. 13:4468. PubMed
  186. Nam J, et al. 2021. Adv Ther (Weinh). 4:. PubMed
  187. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  188. Zhou H, et al. 2021. Cell Death Discov. 7:332. PubMed
  189. Yang Z, et al. 2021. Nat Commun. 12:4299. PubMed
  190. van den Berk P, et al. 2020. Cell Rep. 33:108533. PubMed
  191. Harb H, et al. 2020. Nat Immunol. 1359:21. PubMed
  192. Campolo M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  193. Jia H, et al. 2018. Int J Oncol. 53:949. PubMed
  194. Chao Y, et al. 2020. Sci Adv. 6:eaaz4204. PubMed
  195. Jiang Y, et al. 2021. Nat Commun. 12:742. PubMed
  196. Magee JA, et al. 2021. Stem Cell Reports. 16:20. PubMed
  197. Fujimoto M, et al. 2022. Nat Commun. 13:5408. PubMed
  198. Cané S, et al. 2021. J Immunother Cancer. 9:. PubMed
  199. Ravindran Menon D, et al. 2021. Pharmaceuticals (Basel). 14:. PubMed
  200. Le QV, et al. 2022. Bioact Mater. 15:160. PubMed
  201. Aulova KS, et al. 2022. Molecules. 27:. PubMed
  202. Yang N, et al. 2022. Nat Commun. 13:2336. PubMed
  203. Xu Y, et al. 2016. Nat Commun. 7:12073. PubMed
  204. Zheng DW, et al. 2020. Nat Commun. 3.865972222. PubMed
  205. Pan X, et al. 2019. BMC Complement Altern Med. 19:163. PubMed
  206. Li K, et al. 2020. Nat Commun. 0.795138889. PubMed
  207. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  208. Zukauskas A, et al. 2018. mSphere. 3:e00303. PubMed
  209. Tao Z, et al. 2022. Cells. 11:. PubMed
  210. Tang T, et al. 2022. J Immunother Cancer. 10:. PubMed
  211. Zhou Y, et al. 2022. Theranostics. 12:5488. PubMed
  212. Chen LH, et al. 2021. Sci Rep. 11:19478. PubMed
  213. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  214. Wang J, et al. 2021. Am J Cancer Res. 11:2005. PubMed
  215. Wang F, et al. 2021. Neoplasia. 23:281. PubMed
  216. Guo X, et al. 2020. J Cell Mol Med. . PubMed
  217. Simoni L, et al. 2020. Cell Rep. 33:108330. PubMed
  218. Yu H, et al. 2015. PLoS One. 10: 0143001. PubMed
  219. Tanegashima K et al. 2017. EBioMedicine. 24:247-256 . PubMed
  220. Crowe J, et al. 2020. PLoS Pathog. 16:e1008391. PubMed
  221. Tur J, et al. 2020. Cell Reports. 32(8):108079. PubMed
  222. Mincham KT, et al. 2021. Front Immunol. 11:601494. PubMed
  223. Zheng Y, et al. 2022. Transl Res. :. PubMed
  224. Gawish R, et al. 2022. Elife. 11:. PubMed
  225. Li J, et al. 2022. Nat Commun. 13:1481. PubMed
  226. Roberto MP, et al. 2021. Immunity. 54(8):1807-1824.e14. PubMed
  227. Goldberg EL, et al. 2021. Cell Metabolism. :. PubMed
  228. Martínez-Vicente P, et al. 2019. PLoS Pathog. 15:e1007658. PubMed
  229. Liu WL, et al. 2019. Nat Commun. 10:3199. PubMed
  230. Kubli SP, et al. 2019. Nat Commun. 10:2678. PubMed
  231. Sun Q, et al. 2022. J Inflamm Res. 15:5827. PubMed
  232. Cao Y, et al. 2022. Small. 18:e2203466. PubMed
  233. Li C, et al. 2022. Front Cell Dev Biol. 10:913824. PubMed
  234. Xu Z, et al. 2022. Cell Death Dis. 13:502. PubMed
  235. Pastor Arroyo EM, et al. 2022. Clin Sci (Lond). 136:557. PubMed
  236. Erens C, et al. 2022. Biomedicines. 10:. PubMed
  237. Zhang J, et al. 2021. Stem Cell Res Ther. 12:579. PubMed
  238. Gu Z, et al. 2021. Nat Genet. 53:672. PubMed
  239. Zuo S, et al. 2021. EBioMedicine. 64:103240. PubMed
  240. Zheng QY, et al. 2020. FASEB J. 34:10590. PubMed
  241. Li J, et al. 2021. eLife. 10:00. PubMed
  242. Trivedi S, et al. 2020. Elife. 9:00. PubMed
  243. Tripathi D, et al. 2016. Nat Commun. 7:13896. PubMed
  244. Fan X, et al. 2014. PLoS One. 9:107638. PubMed
RRID
AB_312660 (BioLegend Cat. No. 100203)
AB_312661 (BioLegend Cat. No. 100204)

Antigen Details

Structure
Ig superfamily, CD3/TCR, 20 kD
Distribution

Thymocytes (differentiation dependent), mature T cells, NK-T cells

Function
Antigen recognition, TCR signal transduction, T cell activation
Ligand/Receptor
Peptide antigen/MHC-complex
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Davis MM. 1990. Annu. Rev. Biochem. 59:475.
3. Weiss A, et al. 1994. Cell 76:263.

Gene ID
12502 View all products for this Gene ID
UniProt
View information about CD3 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD3 Reagents Request Custom Conjugation
Description Clone Applications
FITC anti-mouse CD3 17A2 FC
PE anti-mouse CD3 17A2 FC
Purified anti-mouse CD3 17A2 FC,IHC-F,IP,ICC
Alexa Fluor® 647 anti-mouse CD3 17A2 FC,IHC-F,3D IHC,SB
Alexa Fluor® 488 anti-mouse CD3 17A2 FC,IHC-F,3D IHC
Pacific Blue™ anti-mouse CD3 17A2 FC
Alexa Fluor® 700 anti-mouse CD3 17A2 FC
PerCP/Cyanine5.5 anti-mouse CD3 17A2 FC
PE/Cyanine7 anti-mouse CD3 17A2 FC
APC/Cyanine7 anti-mouse CD3 17A2 FC
Brilliant Violet 421™ anti-mouse CD3 17A2 FC,ICC
Brilliant Violet 570™ anti-mouse CD3 17A2 FC
Brilliant Violet 650™ anti-mouse CD3 17A2 FC
Brilliant Violet 785™ anti-mouse CD3 17A2 FC
Brilliant Violet 510™ anti-mouse CD3 17A2 FC
APC anti-mouse CD3 17A2 FC
Ultra-LEAF™ Purified anti-mouse CD3 17A2 FC,IHC-F,IP,ICC
Brilliant Violet 605™ anti-mouse CD3 17A2 FC
Alexa Fluor® 594 anti-mouse CD3 17A2 IHC-F,FC,3D IHC,SB
Brilliant Violet 711™ anti-mouse CD3 17A2 FC
Biotin anti-mouse CD3 17A2 FC,IHC-F
PE/Dazzle™ 594 anti-mouse CD3 17A2 FC
APC/Fire™ 750 anti-mouse CD3 17A2 FC
Brilliant Violet 750™ anti-mouse CD3 17A2 FC
TotalSeq™-A0182 anti-mouse CD3 17A2 PG
TotalSeq™-B0182 anti-mouse CD3 17A2 PG
Spark Blue™ 550 anti-mouse CD3 17A2 FC
Spark NIR™ 685 anti-mouse CD3 17A2 FC
TotalSeq™-C0182 anti-mouse CD3 17A2 PG
APC/Fire™ 810 anti-mouse CD3 17A2 FC
PE/Fire™ 640 anti-mouse CD3 17A2 FC
Spark YG™ 570 anti-mouse CD3 17A2 IHC-F
PE/Fire™ 700 anti-mouse CD3 17A2 FC
PE/Cyanine5 anti-mouse CD3 17A2 FC
Spark Blue™ 574 anti-mouse CD3 Antibody 17A2 FC
Spark Violet™ 423 anti-mouse CD3 17A2 FC
PE/Fire™ 810 anti-mouse CD3 17A2 FC
Spark Red™ 718 anti-mouse CD3 17A2 FC
Spark UV™ 387 anti-mouse CD3 17A2 FC
Go To Top Version: 1    Revision Date: 11/30/2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account